In contrast, LEF1 was able to regulate MMP-7 expression and activity in breast cancer cells [26], whereas another previous study showed that circulating MMP-2 and MMP-9 could be used to potentially classify patients into low risk, high risk, benign disease, and breast cancer [24]. This evidence concerns the gene MMP9 and breast cancer.